Cargando…

Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy

SIMPLE SUMMARY: Immunotherapy, most notably immune checkpoint inhibitors (ICIs), has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC). Although some patients respond well to ICIs, many patients do not benefit from ICIs, leading to disease progression and/or immune-related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honrubia-Peris, Beatriz, Garde-Noguera, Javier, García-Sánchez, Jose, Piera-Molons, Nuria, Llombart-Cussac, Antonio, Fernández-Murga, María Leonor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428366/ https://www.ncbi.nlm.nih.gov/pubmed/34503087 http://dx.doi.org/10.3390/cancers13174280

Ejemplares similares

Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population
por: Garde-Noguera, Javier, et al.
Publicado: (2020)

1764P Prevalence, severity and evolution of Coronavirus disease 19 (COVID-19) infection in cancer patients from Mediterranean population
por: Garde Noguera, J., et al.
Publicado: (2020)

A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target
por: Fernández-Murga, M. Leonor, et al.
Publicado: (2023)

Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study
por: Llombart-Cussac, Antonio, et al.
Publicado: (2023)

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2020)

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2020)

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2020)

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials
por: Fernandez-Martinez, Aranzazu, et al.
Publicado: (2023)

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
por: Gion, María, et al.
Publicado: (2021)

Safety Assessment of Bacteroides uniformis CECT 7771 Isolated from Stools of Healthy Breast-Fed Infants
por: Fernández-Murga, M. Leonor, et al.
Publicado: (2016)

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies
por: Mundt, Filip, et al.
Publicado: (2014)

The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
por: Geenen, Laurie W., et al.
Publicado: (2019)

The prognostic value of biomarkers in stroke
por: Iemolo, Francesco, et al.
Publicado: (2016)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction – A multicenter study
por: Bahuleyan, C.G., et al.
Publicado: (2018)

Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality
por: Andreu-Ballester, Juan Carlos, et al.
Publicado: (2021)

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
por: Arnaldos-Carrillo, María, et al.
Publicado: (2023)

Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients
por: Machiraju, Devayani, et al.
Publicado: (2021)

Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
por: Pabst, Lucile, et al.
Publicado: (2023)

Prognostic value of soluble ST2 in adults with congenital heart disease
por: Geenen, Laurie W, et al.
Publicado: (2019)

Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients
por: Choi, Yu Bum, et al.
Publicado: (2020)

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy
por: Di Leo, Angelo, et al.
Publicado: (2018)

Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2– breast cancer
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

Prognostic Value of Colorectal Cancer Biomarkers
por: Bianchi, Paolo, et al.
Publicado: (2011)

Correction: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Publicado: (2023)

Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma
por: Li, Jian-Jun, et al.
Publicado: (2013)

The Prognostic Value of Serum Soluble TREM-1 on Outcome in Adult Patients with Sepsis
por: Kung, Chia-Te, et al.
Publicado: (2021)

Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19
por: Tomášková, Veronika, et al.
Publicado: (2022)

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors
por: Andreu-Ballester, Juan Carlos, et al.
Publicado: (2020)

Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy
por: He, Zi-Xuan, et al.
Publicado: (2022)

Soluble and EV-Associated Diagnostic and Prognostic Biomarkers in Knee Osteoarthritis Pathology and Detection
por: Moravek, Marko, et al.
Publicado: (2023)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
por: Pan, Yuting, et al.
Publicado: (2023)

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2021)

Evaluating the Prognostic Value of New Cardiovascular Biomarkers
por: Wood, Angela M., et al.
Publicado: (2009)

Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
por: Nowak, Albina, et al.
Publicado: (2014)

The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
por: Zhang, Rongcheng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oe5c5lgddgg1ng0jnnbgavbur2